Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 419026, 8 pages
http://dx.doi.org/10.1155/2014/419026
Research Article

New Drugs on the Internet: The Case of Camfetamine

1Neuroscience and Imaging Department, Chair of Psychiatry, “G. d’Annunzio” University, Via dei Vestini 131, 66100 Chieti, Italy
2School of Life and Medical Sciences, University of Hertfordshire, College Lane, AL10 9AB Hatfield, UK

Received 27 February 2014; Revised 19 May 2014; Accepted 19 May 2014; Published 16 July 2014

Academic Editor: Zsolt Demetrovics

Copyright © 2014 Eduardo Cinosi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. United Nations Office on Drugs and Crime (UNODC), World Drug Report, (United Nations publication, Sales No. E.13.XI.6).
  2. European Monitoring Centre for Drugs and Drug Addiction, “Responding to new psychoactive substances,” Drugs in Focus, No. 22, 2011. View at Google Scholar
  3. United Nations Office on Drugs and Crime (UNODC), “New Psychoactive Substances Report. A Report from the Global SMART Programme,” March 2013.
  4. J. Weinstock, N. Schwartz, and M. F. Kormendy, “Stereochemistry of a 3-phenylnorbornane-2-amine,” Journal of Organic Chemistry, vol. 26, no. 12, pp. 5247–5249, 1961. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. F. Reynolds, Ed., Martindale: The Extra Pharmacopoeia, Royal Pharmaceutical Society, London, UK, 31st edition, 1996.
  6. P. J. van der Merwe and H. S. L. Kruger, “Drugs in sport—results of the past 6 years of dope testing in South Africa,” South African Medical Journal, vol. 82, no. 3, pp. 151–153, 1992. View at Google Scholar · View at Scopus
  7. UK Focal Point on Drugs, “United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012,” Tech. Rep., EMCDDA, 2012. View at Google Scholar
  8. Dipartimento Politiche Antidroga, Presidenza del Consiglio dei Ministri, Nuove Sostanze Psicoattive, National Early Warning System, 2012.
  9. International Narcotics Control Board Convention on Psychotropic Substances (United Nations, 1971), 2011, http://www.incb.org/incb/convention_1971.html.
  10. P. Kavanagh, D. Angelov, J. O'Brien et al., “The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine),” Drug Testing and Analysis, vol. 5, no. 4, pp. 247–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. ReDNet Research Group, Camfetamine Factsheet, University of Hertfordshire, Hatfield, UK, 2012.
  12. “EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino) cyclohexanone,” Tech. Rep., 2013.
  13. P. Dargan and D. Wood, Novel Psychoactive Substances. Classification, Pharmacology and Tossicology, Academic Press Elsevier, London, UK, 2013.
  14. A. N. Nicholson and B. M. Stone, “Heterocyclic amphetamine derivatives and caffeine on sleep in man,” British Journal of Clinical Pharmacology, vol. 9, no. 2, pp. 195–203, 1980. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Welter, P. Kavanagh, and H. H. Maurer, “GC-MS and LC-(high-resolution)-MS n studies on the metabolic fate and detectability of camfetamine in rat urine,” Analytical and Bioanalytical Chemistry, vol. 406, no. 16, pp. 3815–3829, 2014. View at Publisher · View at Google Scholar
  16. M. L. Aizenstein, C. Scavone, M. M. Bernardi, and R. Delucia, “Comparative biochemical and behavioural effects of fencamfamine and DL-amphetamine in rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 7, no. 2-3, pp. 187–194, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Seyfried, “Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study,” Biochemical Pharmacology, vol. 32, no. 15, pp. 2329–2331, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Kuczenski, D. S. Segal, and M. L. Aizenstein, “Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics,” Journal of Neuroscience, vol. 11, no. 9, pp. 2703–2712, 1991. View at Google Scholar · View at Scopus
  19. R. T. Matthews, “Effects of fencamfamine on single unit activity of mesencephalic dopaminergic neurons in rats,” Journal of Neural Transmission—General Section, vol. 71, no. 1, pp. 45–55, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. R. DeLucia, M. M. Bernardi, C. Scavone, and M. L. Aizenstein, “On the mechanism of central stimulation action of fencamfamine,” General Pharmacology: The Vascular System, vol. 15, no. 5, pp. 407–410, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Sayers and S. L. Handley, “Role of catecholamines in the response to various central stimulants,” European Journal of Pharmacology, vol. 23, no. 1, pp. 37–55, 1973. View at Publisher · View at Google Scholar · View at Scopus
  22. R. DeLucia, C. S. Planeta, M. P. Ferreira, M. L. Aizenstein, and C. Scavone, “Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices,” Brazilian Journal of Medical and Biological Research, vol. 30, no. 5, pp. 637–640, 1997. View at Google Scholar · View at Scopus
  23. P. B. Yang, K. D. Atkins, and N. Dafny, “Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats,” European Journal of Pharmacology, vol. 661, no. 1–3, pp. 72–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. S. Segal and A. J. Mandell, “Long term administration of d amphetamine: progressive augmentation of motor activity and stereotypy,” Pharmacology Biochemistry and Behavior, vol. 2, no. 2, pp. 249–255, 1974. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Da Silva Planeta, M. L. Aizenstein, and R. DeLucia, “Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors,” Pharmacology Biochemistry and Behavior, vol. 50, no. 1, pp. 35–40, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. C. R. R. Alves, R. Delucia, and M. T. A. Silva, “Effects of fencamfamine on latent inhibition,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 6, pp. 1089–1093, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. R. R. A. De Aguiar, M. J. L. de Aguiar, R. Delucia, and M. T. A. Silva, “Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 246–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. D. Munhoz, I. Glezer, E. M. Kawamoto et al., “Changes in sodium, potassium-ATPase induced by repeated fencamfamine: The roles of cyclic AMP-dependent protein kinase and the nitric oxide-cyclic GMP pathway,” Neuropharmacology, vol. 45, no. 8, pp. 1151–1159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. DeLucia and C. S. Planeta, “Fencamfamine,” General Pharmacology, vol. 21, no. 2, pp. 161–163, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Winstock and C. Wilkins, “‘Legal highs’ the challenge of new psychoactive sustances,” Transnational Institute, Series on Legislative Reform on Drug Policies, vol. 16, pp. 1–16, 2011, http://www.tni.org/files/download/dlr16.pdf. View at Google Scholar
  31. Research Chemical Wholesale, 2014, http://www.research-chemical-wholesale.com/index/177_143.
  32. Synthemol, 2014, http://synthemol.com/camfetamine.html.
  33. Research Chemical, 2014, https://rcnet-chemicals.com/it/camfetamine.html.
  34. Buy Research Chemical UK, https://http://www.brc-finechemicals.com/News/camfetamine-returns.
  35. ChemicalWire, http://chemicalwire.com/research-chemicals/camfetamine-1.html.
  36. Polatzoheadshop, 2014, http://polatzoheadshop.co.uk/buy-camfetamine-now/.
  37. Buy Research Chemical, 2014, http://www.buyresearchchemical.net/research-chemicals/buy-camfetamine-online/camfetamine-1g.
  38. Buy Camfetamine, http://buycamfet.blogspot.it/2013/08/buy-camfetamine.html.
  39. Thesource, 2014, http://bathsaltsbuy.com/research-chemicals/camfetamine/.
  40. “Buy Camfetamine from China,” 2014, http://legalpowder.cn.com/Camfetamine.html.
  41. Buyanychem, 2014, http://www.buyanychem.com/camfetamine.
  42. Buckled Bonzi, http://buckledbonzi.co.uk/products.php?product=Buy-Camfetamine-.
  43. M. M. Schmidt, A. Sharma, F. Schifano, and C. Feinmann, “‘Legal highs’ on the net-Evaluation of UK-based Websites, products and product information,” Forensic Science International, vol. 206, no. 1–3, pp. 92–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Corazza, F. Schifano, P. Simonato et al., “Phenomenon of new drugs on the internet: the case of ketamine derivative methoxetamine,” Human Psychopharmacol: Clinical and Experimental, vol. 27, no. 2, pp. 145–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Psychonaut, http://www.psychonaut.com/sintetici/38797-camfetamine.html.
  46. Bluelight, 2014, http://www.bluelight.ru/vb/threads/570445-Camfetamine-any-info.
  47. Mental Mana, http://mentalmana.blogspot.it/2013/04/camfetamine-and-femcafamine.html.
  48. Drugs Forum, http://www.drugs-forum.com/forum/showthread.php?t=166410.
  49. Legal Highs Forum, http://www.legalhighsforum.com/showthread.php?15281-Camfetamine.
  50. Topix, 2014, http://www.topix.com/forum/news/drugs.
  51. Opiophile, 2014, http://forum.opiophile.org/archive/index.php/t-34820.html.
  52. The Hip Forum, http://www.hipforums.com/newforums/showthread.php?t=436079.
  53. C. Kelleher, R. Christie, K. Lalor, J. Fox, M. Bowden, and C. O' Donnell, An Overview of New Psychoactive Substances and the Outlets Supplying Them, National Advisory Commitee on Drugs, Centre for Social and Educational Research, Dublin Institute of Technology, Dublin, Ireland, 2011.
  54. F. S. Bersani, O. Corazza, P. Simonato et al., “Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy,” General Hospital Psychiatry, vol. 35, no. 5, pp. 571–573, 2013. View at Publisher · View at Google Scholar
  55. Eurobarometer, “Young people and drugs: Analytical report,” http://ec.europa.eu/public_opinion/flash/fl_233_en.pdf.
  56. F. Schifano, J. Corkery, A. Oyefeso, T. Tonia, and A. H. Ghodse, “Trapped in the “K-hole”: overview of deaths associated with ketamine misuse in the UK (1993–2006),” Journal of Clinical Psychopharmacology, vol. 28, no. 1, pp. 114–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Schifano, O. Corazza, P. Deluca et al., “Psychoactive drug or mystical incense? Overview of the online available information on spice products,” International Journal of Culture and Mental Health, vol. 2, pp. 137–44, 2009. View at Google Scholar
  58. O. Corazza and F. Schifano, “Near-death states reported in a sample of 50 misusers,” Substance Use and Misuse, vol. 45, no. 6, pp. 916–924, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Davies, D. M. Wood, G. Smith et al., “Purchasing “legal highs” on the Internet-is there consistency in what you get?” Quarterly Journal of Mathematics, vol. 103, no. 7, Article ID hcq056, pp. 489–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Ramsey, P. I. Dargan, M. Smyllie et al., “Buying “legal” recreational drugs does not mean that you are not breaking the law,” QJM: An International Journal of Medicine, vol. 103, no. 10, pp. 777–783, 2010. View at Publisher · View at Google Scholar · View at Scopus